Under existing law, single-dose autoinjectible epinephrine is the form of epinephrine approved to be carried and self-administered by students, and acquired, stocked, and administered by schools, authorized entities, and certain staff members. This bill would expand the type of approved epinephrine to include any Food and Drug Administration approved form of single-dose premeasured epinephrine used to administer epinephrine into the human body to prevent or treat a life-threatening allergic reaction.